Dr. Lal Path Labs Ltd. Financial Ratios
LALPATHLAB · Healthcare · Current price ₹1,894.2
P/E ratio
62.6x
P/B ratio
12.8x
ROE
20.1%
ROCE
25.6%
Debt / Equity
0.08
Dividend yield
0.3%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 62.6x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 12.8x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 20.1% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 25.6% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.08 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Dr. Lal Path Labs Ltd.'s latest numbers.
Dr. Lal Path Labs Ltd. profitability
Dr. Lal Path Labs Ltd. generates a return on equity of 20.1% and a return on capital employed of 25.6%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.08 and a P/E of 62.6x, Dr. Lal Path Labs Ltd. is conservatively financed. Our overall business-quality score for the company is 6.2 / 10.
Understand the ratios
More on Dr. Lal Path Labs Ltd.
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.